AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wessbecher, F. W.
Right arrow Articles by Dalley, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wessbecher, F. W.
Right arrow Articles by Dalley, R. W.

American Journal of Neuroradiology, Vol 12, Issue 4 675-679, Copyright © 1991 by American Society of Neuroradiology


ARTICLES

Optimizing brain MR imaging protocols with gadopentetate dimeglumine: enhancement of intracranial lesions on spin-density- and T2-weighted images

FW Wessbecher, KR Maravilla and RW Dalley
Department of Radiology, University of Washington Medical Center, Seattle 98195.

To determine whether long TR MR imaging is best performed before or after IV administration of gadopentetate dimeglumine, we obtained spin- density- and T2-weighted images before and after contrast administration in 21 patients with known intracranial enhancing lesions. Of 25 lesions demonstrating enhancement on T1-weighted sequences, 21 showed mild or moderate enhancement on spin-density- weighted sequences and 20 showed mild enhancement on T2-weighted sequences. Importantly, no spin-density or T2 information was obscured by the administration of gadopentetate dimeglumine, and no T2 shortening effects were visible. Two new foci of enhancement were visible on postcontrast spin-density- and T2-weighted images that were missed on postcontrast T1-weighted images and on precontrast spin- density- and T2-weighted studies. Visualization of new areas of enhancement is the main advantage provided by the long TR images obtained after IV injection of gadopentetate dimeglumine. The most likely reason for the appearance of these newly visualized lesions is thought to be delayed enhancement. This imaging protocol also allows the display of adjacent edema or gliosis and enhancing lesions on a single image. Additionally, in three cases, posterior fossa phase-shift artifacts raised the suspicion of an enhancing lesion on postcontrast T1-weighted images, but the cerebellum was shown to be normal on the postcontrast spin-density- and T2-weighted studies. On the basis of our results, we recommend obtaining long TR images after rather than before the administration of gadopentetate dimeglumine in patients with intracranial enhancing lesions.


This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
N. Ercan, S. Gultekin, H. Celik, T. E. Tali, Y. A. Oner, and G. Erbas
Diagnostic Value of Contrast-Enhanced Fluid-Attenuated Inversion Recovery MR Imaging of Intracranial Metastases
AJNR Am. J. Neuroradiol., May 1, 2004; 25(5): 761 - 765.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
V. P. Mathews, K. S. Caldemeyer, M. J. Lowe, S. L. Greenspan, D. M. Weber, and J. L. Ulmer
Brain: Gadolinium-enhanced Fast Fluid-attenuated Inversion-Recovery MR Imaging
Radiology, April 1, 1999; 211(1): 257 - 263.
[Abstract] [Full Text]